✦ LIBER ✦

Alfred P. Solan prize. Viruses, genes, and cancer. II. Retroviruses and cancer genes

✍ Scribed by J. Michael Bishop

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 474 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850515)55:10<2329::aid-cncr2820551005>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alfred P. Sloan prize. Viruses, genes, a

Alfred P. Sloan prize. Viruses, genes, and cancer. I. The discovery of cellular oncogenes and their role in neoplasia

✍ Harold E. Varmus 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Charles S. Mott prize. Hereditary cancer

Charles S. Mott prize. Hereditary cancers disclose a class of cancer genes

✍ Alfred G. Knudson Jr. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Polymorphisms in drug metabolism genes,

Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer

✍ Beth O. Van Emburgh; Jennifer J. Hu; Edward A. Levine; Libyadda J. Mosley; L. Do 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo

Mutation analysis of p53, K-ras, and BRA

Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression

✍ Daniele Calistri; Claudia Rengucci; Ian Seymour; Arturo Lattuneddu; Anna maria P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract Gene mutations in __APC__, __K‐ras__, and __p53__ are thought to be essential events for colorectal cancer development. Recent data seem to indicate that __K‐ras__ and __p53__ mutations rarely co‐exist in the same tumor, indicating that these alterations do not represent a synergistic e

Characterization of topoisomerase IIα ge

Characterization of topoisomerase IIα gene amplification and deletion in breast cancer

✍ Tero A.H. Järvinen; Minna Tanner; Maarit Bärlund; Åke Borg; Jorma Isola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Topoisomerase II␣ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a

Alterations and hypermethylation of the

Alterations and hypermethylation of the p14ARF gene in gastric cancer

✍ Satoru Iida; Yoshimitsu Akiyama; Tomoko Nakajima; Wataru Ichikawa; Zenro Nihei; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 2 views

p14 ARF , generated through an alternative splicing process that replaces the first exon, 1␣, of p16 INK4a with exon 1␤, located >15 kb upstream of exon 1␣, has been shown to function as a growth suppressor. We examined 11 gastric cancer cell lines for mRNA expression, homozygous deletion, mutation,